Your session is about to expire
← Back to Search
Teach-back Education Method for Wound Care Compliance
N/A
Recruiting
Led By Christina Wong, MD
Research Sponsored by Case Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 2 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will help researchers understand if the teach-back method is an effective way to educate patients on wound care and improve their experience.
Who is the study for?
This trial is for English-speaking individuals getting their first Mohs Micrographic Surgery on the lower extremities at a specific outpatient clinic. It's not for those who've had this surgery before, or have mental, learning, visual disabilities, or dementia.
What is being tested?
The study tests the 'teach-back' method where patients are educated about wound care post-surgery using an ask-tell-ask approach to improve satisfaction and adherence to care instructions.
What are the potential side effects?
There are no direct medical side effects from participating in this trial as it involves educational methods rather than medication or invasive treatments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 2 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Complication incidence post-operatively
Number of phone calls made post-operatively by participants
Patient experience as measured by participant satisfaction survey
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Ask-tell-ask methodExperimental Treatment3 Interventions
Study team will provide participant education using the ask-tell-ask method. Participants will receive a post-operative instruction sheet containing detailed information regarding wound care for reference and will receive a phone call at 1 week to inquire about wound care adherence. Participants will come to clinic at 2 weeks to have wounds assessed in addition to answering surveys regarding wound care adherence and participant experience.
Group II: Standard of Care (SOC)Active Control3 Interventions
Participants will receive SOC education from the researcher. Participants will receive a post-operative instruction sheet containing detailed information regarding wound care for reference and will receive a phone call at 1 week to inquire about wound care adherence. Participants will come to clinic at 2 weeks to have wounds assessed in addition to answering surveys regarding wound care adherence and participant experience.
Find a Location
Who is running the clinical trial?
Case Comprehensive Cancer CenterLead Sponsor
469 Previous Clinical Trials
33,430 Total Patients Enrolled
Christina Wong, MDPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with mental, learning, or visual disabilities.You have been diagnosed with dementia.You have previously had Mohs Micrographic Surgery, no matter where it was done on your body.
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care (SOC)
- Group 2: Ask-tell-ask method
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.